| abstract |
Per 100% by weight: -60% to 80% by weight gelled aqueous phase (A1), gelled aqueous phase (A1) containing anti-inflammatory substances, -20% to 40% by weight fat Phase (A2) for at least one emulsification selected from the elements of the group consisting of at least one oil and an emulsifying system consisting of an alkyl polyglycoside composition and a composition of an alkyl polyglycoside and a fatty alcohol. Surfactants (Si) and elements of the group consisting of polyglycerol esters, emulsified polyglycerol esters, polyhydroxystearate polyglycols, polyhydroxystearate polyglycerols and emulsified polyhydroxystearate polyglycerols. A pharmaceutical composition for topical use in the form of a water-in-oil emulsion comprising a fatty phase (A2) comprising an emulsifying system comprising a combination with at least one emulsifying surfactant (S2) selected from. [Selection diagram] None |